ACI
JAZZ icon

AMP Capital Investors’s Jazz Pharmaceuticals JAZZ Stock Holding History

AMP Capital Investors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,805
Closed -$2.32M – 590
2021
Q3 		$2.32M Sell
17,805
-1,941
-10% -$293K 0.01% 701
2021
Q2 		$3.51M Sell
19,746
-7,327
-27% -$1.27M 0.02% 676
2021
Q1 		$4.46M Sell
27,073
-6,004
-18% -$988K 0.02% 635
2020
Q4 		$5.44M Buy
33,077
+1,659
+5% +$247K 0.03% 558
2020
Q3 		$4.39M Sell
31,418
-38,209
-55% -$4.74M 0.03% 569
2020
Q2 		$7.63M Sell
69,627
-2,213
-3% -$245K 0.05% 400
2020
Q1 		$7.16M Sell
71,840
-12,724
-15% -$1.65M 0.05% 361
2019
Q4 		$12.6M Buy
84,564
+44,621
+112% +$6.07M 0.07% 310
2019
Q3 		$5.08M Buy
39,943
+6,054
+18% +$812K 0.03% 531
2019
Q2 		$4.68M Sell
33,889
-748
-2% -$101K 0.03% 538
2019
Q1 		$4.85M Buy
34,637
+13,035
+60% +$1.7M 0.03% 544
2018
Q4 		$2.63M Buy
21,602
+5,409
+33% +$802K 0.02% 661
2018
Q3 		$2.69M Hold
16,193
– – 0.01% 695
2018
Q2 		$2.79M Sell
16,193
-3,440
-18% -$562K 0.02% 682
2018
Q1 		$2.9M Sell
19,633
-3,300
-14% -$484K 0.02% 675
2017
Q4 		$3.09M Hold
22,933
– – 0.02% 676
2017
Q3 		$3.35M Sell
22,933
-595
-3% -$90K 0.02% 634
2017
Q2 		$3.67M Sell
23,528
-6,171
-21% -$944K 0.02% 597
2017
Q1 		$4.33M Sell
29,699
-348
-1% -$45.3K 0.03% 568
2016
Q4 		$3.23M Sell
30,047
-5,209
-15% -$580K 0.02% 640
2016
Q3 		$4.34M Buy
35,256
+20,334
+136% +$2.74M 0.03% 556
2016
Q2 		$2.1M Sell
14,922
-100
-0.7% -$14.7K 0.01% 696
2016
Q1 		$1.86M Hold
15,022
– – 0.01% 721
2015
Q4 		$2.15M Sell
15,022
-2,000
-12% -$277K 0.01% 704
2015
Q3 		$2.12M Buy
17,022
+2,600
+18% +$448K 0.02% 675
2015
Q2 		$2.46M Sell
14,422
-100
-0.7% -$18K 0.02% 655
2015
Q1 		$2.55M Sell
14,522
-3,460
-19% -$594K 0.02% 647
2014
Q4 		$2.93M Buy
17,982
+13,978
+349% +$2.32M 0.02% 634
2014
Q3 		$649K Buy
+4,004
New +$616K ﹤0.01% 962

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AMP Capital Investors's JAZZ Position: Q4 2021 in Review

AMP Capital Investors sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 17,805 shares — an estimated $2.32M sold.

AMP Capital Investors first reported a position in JAZZ in Q3 2014 and held it in 29 quarters. The position peaked at $12.6M in Q4 2019. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

  • AMP Capital Investors reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 17,805 Jazz Pharmaceuticals shares in Q4 2021, an estimated $2.32M.
  • AMP Capital Investors first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 29 quarters.
  • AMP Capital Investors's Jazz Pharmaceuticals position peaked at $12.6M in Q4 2019.
  • 454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.